相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer
Raul Ortiz et al.
AAPS JOURNAL (2015)
Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap® System
Mirko Koziolek et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The Potential of Liposomes with Carbonic Anhydrase IX to Deliver Anticancer Ingredients to Cancer Cells in Vivo
Huei Leng Helena Ng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Getting into the colon: approaches to target colorectal cancer
Mayur M. Patel
EXPERT OPINION ON DRUG DELIVERY (2014)
Epidermal growth factor receptor gene expression evaluation in colorectal cancer patients
G. Motalleb et al.
INDIAN JOURNAL OF CANCER (2014)
Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatment
A. Bose et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Functionalized nanofibers as drug-delivery systems for osteochondral regeneration
Evzen Amler et al.
NANOMEDICINE (2014)
Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
C. Thibault et al.
ONCOLOGIE (2014)
Effect of StarD13 on colorectal cancer proliferation, motility and invasion
Anita Nasrallah et al.
ONCOLOGY REPORTS (2014)
MUTYH-associated colorectal cancer and adenomatous polyposis
Satoru Yamaguchi et al.
SURGERY TODAY (2014)
A Promising Approach to Provide Appropriate Colon Target Drug Delivery Systems of Vancomycin HCL: Pharmaceutical and Microbiological Studies
Kadria A. Elkhodairy et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Targeted therapy in metastatic colorectal cancer - An example of personalised medicine in action
V. Heinemann et al.
CANCER TREATMENT REVIEWS (2013)
Colon targeting: an emerging frontier for oral insulin delivery
Mayur Mahendrakumar Patel
EXPERT OPINION ON DRUG DELIVERY (2013)
A Novel Germline Mutation in Exon 10 of the SMAD4 Gene in a Familial Juvenile Polyposis
Myung Jin Jee et al.
GUT AND LIVER (2013)
Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells
Meihua Yu et al.
NANOSCALE (2013)
Molecular Mechanisms of Fibroblast Growth Factor Signaling in Physiology and Pathology
Artur A. Belov et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
The CpG island methylator phenotype in colorectal cancer: Progress and problems
Laura A. E. Hughes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
Germline mutations of the SMAD4 promoter in juvenile polyposis
Jennifer C. Carr et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: A potential therapeutic target in colorectal cancer
Yoko Matsuda et al.
CANCER LETTERS (2011)
Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: Preparation, characterization and in vivo evaluation in rats
Dalia M. Ghorab et al.
DRUG DELIVERY (2011)
Re-challenge and the concept of lines of therapy in metastatic colorectal cancer
Aimery de Gramont
EUROPEAN JOURNAL OF CANCER (2011)
Inhibition of Matrix Metalloproteinase 14 (MMP-14)-mediated Cancer Cell Migration
Kevin Zarrabi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis
Gilbert Spizzo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Targeted drug delivery to tumors: Myths, reality and possibility
You Han Bae et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Willem van Gijn et al.
LANCET ONCOLOGY (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion
Narendra V. Sankpal et al.
BREAST CANCER RESEARCH (2011)
Targeted Therapeutic Agents for Colorectal Cancer
Cheng E. Chee et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2010)
Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide
Xiang Chen et al.
JOURNAL OF CONTROLLED RELEASE (2010)
New targeted-colon delivery system: in vitro and in vivo evaluation using X-ray imaging
Alaa Eldeen Bakry Yassin et al.
JOURNAL OF DRUG TARGETING (2010)
Evolving Treatment of Advanced Colon Cancer
Neil H. Segal et al.
ANNUAL REVIEW OF MEDICINE (2009)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Lung metastases from colorectal cancer: surgical resection and prognostic factors
Nuno Rama et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2009)
5-Fluorouracil and its active metabolite FdUMP cause DNA damage in human SW620 colon adenocarcinoma cell line
Renata Matuo et al.
JOURNAL OF APPLIED TOXICOLOGY (2009)
Nuclear signalling by tumour-associated antigen EpCAM
Dorothea Maetzel et al.
NATURE CELL BIOLOGY (2009)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Compliance and Effective Manapement of the Hand-Foot Syndrome in Colon Cancer Patients Receiving Capecitabine as Adjuvant Chemotherapy
Hyun-Sook Son et al.
YONSEI MEDICAL JOURNAL (2009)
Study on colon-specific 5-Fu pH-enzyme Di-dependent chitosan microspheres
Xiu-Li Zhao et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2008)
CD44 is of Functional Importance for Colorectal Cancer Stem Cells
Lei Du et al.
CLINICAL CANCER RESEARCH (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
The RAS/MAPK syndromes: Novel roles of the RAS pathway in human genetic disorders
Yoko Aoki et al.
HUMAN MUTATION (2008)
Gut instincts: Explorations in intestinal physiology and drug delivery
Emma L. McConnell et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
Leonard B. Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man
Emma L. McConnell et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems
Valentine C. Ibekwe et al.
PHARMACEUTICAL RESEARCH (2008)
Somatic APC mosaicism: an underestimated cause of polyposis coli
F. J. Hes et al.
GUT (2008)
Palliation of colorectal cancer
Nir Wasserberg et al.
SURGICAL ONCOLOGY-OXFORD (2007)
COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia
M. Farooqui et al.
BRITISH JOURNAL OF CANCER (2007)
Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model
Shao-Jiang Zheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans
Valentine C. Ibekwe et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo
C Mamot et al.
CANCER RESEARCH (2005)
Neoadjuvant treatment of unresectable colorectal liver metastases:: correlation between tumour response and resection rates
G Folprecht et al.
ANNALS OF ONCOLOGY (2005)
Prostaglandin E2 stimulates the β-catenin/T cell factor-dependent transcription in colon cancer
JY Shao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Determining the oxidation states of manganese in PC12 and nerve growth factor-induced PC12 cells
KK Gunter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives
JP Spano et al.
ANNALS OF ONCOLOGY (2005)
Large submicroscopic genomic APC deletions are a common cause of typical familial adenomatous polyposis
S Aretz et al.
JOURNAL OF MEDICAL GENETICS (2005)
Bacteriology of abdominal wounds in elective open colon surgery: a prospective study of 100 surgical wounds
PR Fa-Si-Oen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposlis (FAP): A Belgian study
G Michils et al.
HUMAN MUTATION (2005)
Impact of EGFR expression on colorectal cancer patient prognosis and survival
JP Spano et al.
ANNALS OF ONCOLOGY (2005)
Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases
R Adam
ANNALS OF ONCOLOGY (2003)
Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC
OM Sieber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis
MG Sayed et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
Tumorigenesis -: RAF/RAS oncogenes and mismatch-repair status
H Rajagopalan et al.
NATURE (2002)
Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer
G Deng et al.
BRITISH JOURNAL OF CANCER (2002)
In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery
ME Sangalli et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: A new survival standard
LB Saltz et al.
ONCOLOGIST (2001)
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
G Steinbach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
